(redirected from hypogonadotropic)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to hypogonadotropic: Kallmann syndrome, hypogonadotropic amenorrhea


 (hī′pō-gō′năd-ĭz′əm, -gŏn′ə-dĭz′əm)
Inadequate functioning of the testes or ovaries as manifested by deficiencies in gametogenesis or the secretion of gonadal hormones.


(ˌhaɪ pəˈgoʊ næˌdɪz əm, -ˈgɒn æ-)

n. Pathol.
1. diminished hormonal or reproductive functioning in the testes or the ovaries.
2. a manifestation of this, as delayed pubescence.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hypogonadism - incompetence of the gonads (especially in the male with low testosterone); results in deficient development of secondary sex characteristics and (in prepubertal males) a body with long legs and a short trunk
eunuchoidism, male hypogonadism - the state of being a eunuch (either because of lacking testicles or because they failed to develop)
Kallman's syndrome - hypogonadism with anosmia; a congenital sexual disorder that prevents the testicles from maturing at puberty
incompetence - inability of a part or organ to function properly
References in periodicals archive ?
Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma.
Testosterone gel is an androgen indicated for replacement therapy in males for conditions associated with deficiency or absence of endogenous testosterone including primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired).
Food and Drug Administration (FDA) in May 2014 for replacement therapy in adult men with conditions associated with deficiency or absence of endogenous testosterone, including primary hypogonadism (congenital or acquired) or hypogonadotropic hypogonadism (congenital or acquired).
The FDA has approved Natesto in May this year for replacement therapy in males for conditions related to a deficiency or lack of endogenous testosterone including primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired).
Other infertility implications and causes such as hyperprolactinemia, hypothyroidism, and hypogonadotropic reasons (3.
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis.
assessed the relationship with testosterone levels and psychological symptoms in young male patients with congenital hypogonadotropic hypogonadism (CHH).
Hypogonadism is further classified as either a normo-, hyper-, or hypogonadotropic state, which is differentiated on the basis of laboratory measurement of LH and FSH.
The depot formulation of testosterone undecanoate (TU), in castor oil and benzoyl benzoate, has been approved for treating adult men with primary hypogonadism or hypogonadotropic hypogonadism, congenital or acquired.
Hypergonadotropic hypogonadism in 3 patients (6%), hypogonadotropic hypogonadism in 1 female patient (2%), and small testicular volume in respect to age in 3 male patients (8.
Acquired factors include bone marrow expansion secondary to ineffective erythropiesis with cortical thinning, hypogonadotropic hypogonadism, hypothyroidism, hypoparathyroidism, diabetes mellitus, direct toxic effects of iron overload on osteoblast number and activity, deleterious effects of desferoxamine on the bone metabolism, the negative impact of chelation therapy on fibroblast proliferation and collagen synthesis, calcium and zinc deficiencies, low vitamin D levels due to aberrant vitamin D-parathyroid hormone axis and reduced physical activity (8-13).